ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bioactive Components and Potential Mechanism Prediction of Kui Jie Kang against Ulcerative Colitis via Systematic Pharmacology and UPLC-QE-MS Analysis

He, Jinbiao; Wan, Chunping; Li, Xiaosi; Zhang, Zishu; Yang, Yu; Wang, Huaning; Qi, Yan*云南大学; y
Evidence-based Complementary and Alternative Medicine2022-6-21DOI: 10.1155/2022/9122315
1被引18阅读
引用收藏
分享

摘要

Kui Jie Kang (KJK)-a traditional Chinese medicine-has demonstrated clinical therapeutic efficacy against ulcerative colitis (UC). However, the active compounds and their underlying mechanisms have not yet been fully characterized. Therefore, the current study sought to identify the volatile compounds in KJK responsible for eliciting the therapeutic effect against UC, while also analyzing key targets and potential mechanisms. To this end, systematic network pharmacology analysis was employed to obtain UC targets by using GeneCards, DisGeNET, OMIM, among others. A total of 145 candidate ingredients, 412 potential targets of KJK (12 herbs), and 1605 UC targets were identified. Of these KJK and UC targets, 205 intersected and further identified AKT1, JUN, MAPK, ESR, and TNF as the core targets and the PI3K/AKT signaling pathway as the top enriched pathway. Moreover, molecular docking and ultra-performance liquid chromatography Q Exactive-mass spectrometry analysis identified quercetin, kaempferol, luteolin, wogonin, and nobiletin as the core effective compounds of KJK. In vivo murine studies revealed that KJK exposure increases the body weight and colon length, while reducing colonic epithelial injury, and the expression of inflammatory factors in colitis tissues such as TNF-alpha, IL-6, and IL-1 beta. Furthermore, KJK treatment downregulates the expression of pi3k and akt genes, as well as p-PI3K/PI3K and p-AKT/AKT proteins. Collectively, these findings describe the therapeutic effects and mechanisms of KJK in UC and highlight KJK as a potentially valuable therapeutic option for UC via modulation of the PI3K/AKT signaling pathway, thus providing a theoretical reference for the broader application of KJK in the clinical management of UC.

学科与关键词

关键词
INFLAMMATIONFLAVONOIDSPATHWAYS
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-06-21
卷期
第 2022 卷
页码
9122315
DOI
10.1155/2022/9122315
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81960868]; Yunnan Provincial Science and Technology Department - Applied Basic Research Joint Special Funds of Yunnan University of Chinese Medicine, High-level TCM talents (reserve talents) project of Yunnan [2018FF001 (011), 2019FF002 (071), 202001AZ070001-051, 202101AZ070001-013]

作者

  • H

    He, Jinbiao (第一作者)

    yunnan univ

  • W

    Wan, Chunping

    yunnan univ

查看全部 7 位作者收起作者
  • L

    Li, Xiaosi

    yunnan univ

  • Z

    Zhang, Zishu

  • Y

    Yang, Yu

    yunnan univ

  • W

    Wang, Huaning

    yunnan univ

  • Q

    Qi, Yan (通讯)

    yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417